Thomas Force

Overview

Best Publications

• Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

  Juan Carlos Plana;Maurizio Galderisi;Ana Barac;Michael S. Ewer

  1875
  Citations

• Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

  Risto Kerkelä;Luanda Grazette;Rinat Yacobi;Cezar Iliescu

  1373
  Citations

• Heart failure: preventing disease and death worldwide.

  Piotr P. Ponikowski;Stefan D. Anker;Khalid F. AlHabib;Martin R. Cowie

  1323
  Citations

• Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

  Tammy F Chu;Tammy F Chu;Maria A Rupnick;Maria A Rupnick;Risto Kerkela;Susan M Dallabrida

  1207
  Citations

• Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium

  A B Abou-Samra;H Jüppner;T Force;M W Freeman

  997
  Citations

• Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.

  Thomas Force;Daniela S. Krause;Richard A. Van Etten

  923
  Citations

• Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo

  Takashi Matsui;Jingzang Tao;Federica del Monte;Kyung-Han Lee

  826
  Citations

• Protein kinase cascades in the regulation of cardiac hypertrophy

  Gerald W. Dorn;Thomas Force

  814
  Citations

• Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

  Beth A. Rose;Thomas Force;Yibin Wang

  789
  Citations

• Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy

  Syed Haq;Gabriel Choukroun;Zhao Bin Kang;Hardeep Ranu

  523
  Citations

• Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

  Syed Haq;Gabriel Choukroun;Hae Lim;Kevin M. Tymitz

  521
  Citations

• Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.

  Thomas Eschenhagen;Thomas Force;Michael S. Ewer;Gilles W. De Keulenaer

  489
  Citations

• Growth Factors and Mitogen-Activated Protein Kinases

  Thomas Force;Joseph V. Bonventre

  481
  Citations

• 17β-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling

  Richard D. Patten;Isaac Pourati;Mark J. Aronovitz;Jason Baur

  422
  Citations

• Cyclophilin D controls mitochondrial pore–dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice

  John W. Elrod;Renee Wong;Shikha Mishra;Ronald J. Vagnozzi

  421
  Citations

• Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics

  Ming Hui Chen;Risto Kerkelä;Thomas Force

  407
  Citations

• Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

  Thomas Force;Kyle L. Kolaja

  399
  Citations

• The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion.

  C M Pombo;J V Bonventre;J Avruch;J R Woodgett

  331
  Citations

• Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart CROSS-TALK BETWEEN CARDIAC HYPERTROPHIC SIGNALING PATHWAYS

  Leon J. De Windt;Hae W. Lim;Syed Haq;Thomas Force

  303
  Citations

• Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: Implications for herceptin-induced cardiomyopathy

  Luanda P. Grazette;Wolfgang Boecker;Takashi Matsui;Marc Semigran

  274
  Citations